Heart Failure, Systolic Clinical Trial
— hypoxheartOfficial title:
Hypoxic Conditioning Combined With Exercise Training in Heart Failure Patient: a Randomised, Controled, Single Blind Study
NCT number | NCT03537079 |
Other study ID # | 38RC17.347 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2020 |
Est. completion date | May 2022 |
Heart failure impairs quality of life and exercise capacity, despite an optimal medical therapy. Alternative methods, like hypoxic conditioning coupled to exercise training, must be explored and describe
Status | Recruiting |
Enrollment | 63 |
Est. completion date | May 2022 |
Est. primary completion date | May 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: - patient available for exercise training - stable heart failure state I-II New York Heart Association (NYHA) with altered ejection fraction (EF = 40 %) - signed informed consent Exclusion Criteria: - unstable ischemic cardiopathy - right ventricle dysfunction - uncontrolled arrythmias - rest elevated in pulmonary artery pressure (= 45 mmHg) - migraine - high altitude trip above 2500 m high during study period - impossibility to realise a maximal bicycle exercise test |
Country | Name | City | State |
---|---|---|---|
France | University Hospital | Grenoble |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Grenoble |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | maximal oxygen uptake in ml/min/kg | The maximal exercise capacity will be assessed by an incremental maximal bicycle exercise test | after 8 weeks of training and conditioning | |
Secondary | End diastolic left ventricle diameter in mm | In parasternal long axe, the end diastolic left ventricle diameter | After 8 weeks of training and conditioning | |
Secondary | systolic left ventricle ejection fraction in % | the systolic left ventricle ejection fraction will be assessed by Simpson's method in 4 and 2 cavity views | After 8 weeks of training and conditioning | |
Secondary | flow mediated dilatation (FMD) in % | The rest FMD will be assessed by echocardiography by using the % of variation of the brachial artery diameter 10 minutes after occlusion. | After 8 weeks of training and conditioning | |
Secondary | systolic and diastolic blood pressure control in mmHg | 24 hours ambulatory blood pressure monitoring | After 8 weeks of training and conditioning |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03227393 -
The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG
|
N/A | |
Recruiting |
NCT04528004 -
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
|
Early Phase 1 | |
Recruiting |
NCT04703842 -
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
|
Phase 1/Phase 2 | |
Recruiting |
NCT04522609 -
Electrostimulation of Skeletal Muscles in Patients Listed for a Heart Transplant
|
N/A | |
Completed |
NCT05475028 -
Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET)
|
||
Not yet recruiting |
NCT06240403 -
Digoxin and Senolysis in Heart Failure and Diabetes Mellitus
|
Phase 2 | |
Not yet recruiting |
NCT05988749 -
Digital Remote Home Monitoring for Heart Failure
|
N/A | |
Recruiting |
NCT04950218 -
The Psoriasis Echo Study
|
||
Suspended |
NCT04701112 -
Acute Hemodynamic Effects of Pacing the His Bundle in Heart Failure
|
N/A | |
Completed |
NCT03305692 -
ECG Belt vs. Echocardiographic Optimization of CRT
|
N/A | |
Recruiting |
NCT05933083 -
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
|
N/A | |
Enrolling by invitation |
NCT03903107 -
The Fluoroless-CSP Trial Using Electroanatomic Mapping
|
N/A | |
Withdrawn |
NCT04872959 -
TRANSFORM Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT02920918 -
Treatment of Diabetes in Patients With Systolic Heart Failure
|
Phase 4 | |
Completed |
NCT02334891 -
Kyoto Congestive Heart Failure Study
|
||
Recruiting |
NCT03553303 -
Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin
|
Phase 4 | |
Recruiting |
NCT04083690 -
Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients
|
N/A | |
Recruiting |
NCT03830957 -
Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker
|
N/A | |
Recruiting |
NCT06121323 -
Physiological Effects of Lactate in Individuals With Chronic Heart Failure
|
N/A | |
Completed |
NCT03351283 -
Effect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart Failure
|
N/A |